Ending TB: the race to control a disease in hiding

Ending TB: the race to control a disease in hiding

“The whole thing about TB is you just don’t know how you got it,” says 54-year old Amina Scully, a London resident and recent survivor of tuberculosis. Scully developed symptoms of tuberculosis (TB) in 2014 when she returned to London after a decade living on the...

Professor Brendan Wren

  • Professor Brendan Wren is Professor of Microbial Pathogenesis and Dean of Faculty of Infectious and Tropical Diseases at the London School of Hygiene & Tropical Medicine. His research interests predominantly involve determining the genetic basis by which bacterial pathogens cause disease and exploiting this to develop vaccines against them.

  • Professor John Edmunds

  • Professor John Edmunds, OBE, is Dean of Faculty of Epidemiology & Population Health at the London School of Hygiene & Tropical Medicine. His research focuses on infectious disease modelling and using data to help guide decision-making bodies internationally. He designed the ring vaccination trial design used to test an Ebola vaccine in Guinea during rhe 2014 epidemic and sits on the UK government’s Joint Committee on Vaccination and Immunisation

  • Professor Liam Smeeth

  • Professor Liam Smeeth is Professor of Clinical Epidemiology  at the London School of Hygiene & Tropical Medicine. He is a researcher, clinician and general practitioner and led a comprehensive study in 2004 which showed there was no link between autism and MMR.

  • Amina Scully is a recent TB survivor living in London in the UK. After ten years in Spain, she returned to the UK in 2013 and soon after contracted TB, which went on to infect her spine. She was on treatment for more than one year and is now cured of the disease and volunteering at the Whittington Hospital in London, where she was treated.

  • Amina Scully is a recent TB survivor living in London in the UK. After ten years in Spain, she returned to the UK in 2013 and soon after contracted TB, which went on to infect her spine. She was on treatment for more than one year and is now cured of the disease and volunteering at the Whittington Hospital in London, where she was treated.

  • Amina Scully is a recent TB survivor living in London in the UK. After ten years in Spain, she returned to the UK in 2013 and soon after contracted TB, which went on to infect her spine. She was on treatment for more than one year and is now cured of the disease and volunteering at the Whittington Hospital in London, where she was treated.

  • Amina Scully is a recent TB survivor living in London in the UK. After ten years in Spain, she returned to the UK in 2013 and soon after contracted TB, which went on to infect her spine. She was on treatment for more than one year and is now cured of the disease and volunteering at the Whittington Hospital in London, where she was treated.

  • Amina Scully is a recent TB survivor living in London in the UK. After ten years in Spain, she returned to the UK in 2013 and soon after contracted TB, which went on to infect her spine. She was on treatment for more than one year and is now cured of the disease and volunteering at the Whittington Hospital in London, where she was treated.

  • Amina Scully is a recent TB survivor living in London in the UK. After ten years in Spain, she returned to the UK in 2013 and soon after contracted TB, which went on to infect her spine. She was on treatment for more than one year and is now cured of the disease and volunteering at the Whittington Hospital in London, where she was treated.

  • Amina Scully is a recent TB survivor living in London in the UK. After ten years in Spain, she returned to the UK in 2013 and soon after contracted TB, which went on to infect her spine. She was on treatment for more than one year and is now cured of the disease and volunteering at the Whittington Hospital in London, where she was treated.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Mario Raviglione is Director of the Global TB Programme at the World Health Organization. He is also a professor at the medical schools of the University of Brescia and the University of Modena & Reggio Emilia in Italy. At WHO his title involves being responsible for setting norms, policies and standards on global TB control, coordinating technical support, monitoring the global situation, and developing innovative interventions through translation of new evidence into policies & practice.

  • Dr Mario Raviglione is Director of the Global TB Programme at the World Health Organization. He is also a professor at the medical schools of the University of Brescia and the University of Modena & Reggio Emilia in Italy. At WHO his title involves being responsible for setting norms, policies and standards on global TB control, coordinating technical support, monitoring the global situation, and developing innovative interventions through translation of new evidence into policies & practice.

  • Dr Richard White is Reader in Infectious Disease Modelling and leads the TB modelling group at the School. He is also Director of the TB Modelling and Analysis Consortium. His research focuses on mathematical and statistical modelling of the transmission and control of infectious diseases, particularly HIV and TB.

  • Dr Richard White is Reader in Infectious Disease Modelling and leads the TB modelling group at the School. He is also Director of the TB Modelling and Analysis Consortium. His research focuses on mathematical and statistical modelling of the transmission and control of infectious diseases, particularly HIV and TB.

  • Dr Richard White is Reader in Infectious Disease Modelling and leads the TB modelling group at the School. He is also Director of the TB Modelling and Analysis Consortium. His research focuses on mathematical and statistical modelling of the transmission and control of infectious diseases, particularly HIV and TB.

  • Dr Richard White is Reader in Infectious Disease Modelling and leads the TB modelling group at the School. He is also Director of the TB Modelling and Analysis Consortium. His research focuses on mathematical and statistical modelling of the transmission and control of infectious diseases, particularly HIV and TB.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Prof David Moore is Professor of Infectious Diseases and Tropical Medicine at the School. He also leads a TB research group in Lima, Peru and is a consultant at the Hospital for Tropical Diseases in London. His research focuses on improved diagnostics for TB, particularly drug-resistant TB, and understanding the co-epidemic of TB and diabetes.

  • Prof David Moore is Professor of Infectious Diseases and Tropical Medicine at the School. He also leads a TB research group in Lima, Peru and is a consultant at the Hospital for Tropical Diseases in London. His research focuses on improved diagnostics for TB, particularly drug-resistant TB, and understanding the co-epidemic of TB and diabetes.

  • Prof David Moore is Professor of Infectious Diseases and Tropical Medicine at the School. He also leads a TB research group in Lima, Peru and is a consultant at the Hospital for Tropical Diseases in London. His research focuses on improved diagnostics for TB, particularly drug-resistant TB, and understanding the co-epidemic of TB and diabetes.

  • Prof David Moore is Professor of Infectious Diseases and Tropical Medicine at the School. He also leads a TB research group in Lima, Peru and is a consultant at the Hospital for Tropical Diseases in London. His research focuses on improved diagnostics for TB, particularly drug-resistant TB, and understanding the co-epidemic of TB and diabetes.

  • Prof David Moore is Professor of Infectious Diseases and Tropical Medicine at the School. He also leads a TB research group in Lima, Peru and is a consultant at the Hospital for Tropical Diseases in London. His research focuses on improved diagnostics for TB, particularly drug-resistant TB, and understanding the co-epidemic of TB and diabetes.

  • Dr Richard White is Reader in Infectious Disease Modelling and leads the TB modelling group at the School. He is also Director of the TB Modelling and Analysis Consortium. His research focuses on mathematical and statistical modelling of the transmission and control of infectious diseases, particularly HIV and TB.

  • Dr Richard White is Reader in Infectious Disease Modelling and leads the TB modelling group at the School. He is also Director of the TB Modelling and Analysis Consortium. His research focuses on mathematical and statistical modelling of the transmission and control of infectious diseases, particularly HIV and TB.

  • Dr Helen Fletcher is Senior Lecturer in Immunology and Director of the TB Centre at the School. Her research focuses on vaccine development for TB and malaria through understanding the immunology behind the diseases and the mechanisms needed for protection.

  • Dr Richard White is Reader in Infectious Disease Modelling and leads the TB modelling group at the School. He is also Director of the TB Modelling and Analysis Consortium. His research focuses on mathematical and statistical modelling of the transmission and control of infectious diseases, particularly HIV and TB.

  • Dr Richard White is Reader in Infectious Disease Modelling and leads the TB modelling group at the School. He is also Director of the TB Modelling and Analysis Consortium. His research focuses on mathematical and statistical modelling of the transmission and control of infectious diseases, particularly HIV and TB.

  • Marek Lalli is a Research Assistant with the TB Modelling Group. He supports the development of TIME Impact, a modelling tool to guide in-country policymaking and provides epidemiological and mathematical modelling support to National TB Control Programmes.

  • Marek Lalli is a Research Assistant with the TB Modelling Group. He supports the development of TIME Impact, a modelling tool to guide in-country policymaking and provides epidemiological and mathematical modelling support to National TB Control Programmes.

  • Marek Lalli is a Research Assistant with the TB Modelling Group. He supports the development of TIME Impact, a modelling tool to guide in-country policymaking and provides epidemiological and mathematical modelling support to National TB Control Programmes.

  • Prof David Moore is Professor of Infectious Diseases and Tropical Medicine at the School. He also leads a TB research group in Lima, Peru and is a consultant at the Hospital for Tropical Diseases in London. His research focuses on improved diagnostics for TB, particularly drug-resistant TB, and understanding the co-epidemic of TB and diabetes.